Kinaset Therapeutics: Series BDevelops inhaled therapies for severe respiratory diseasesOct 4, 2026RoundOSKinaset TherapeuticsCompany profile and funding historySourcesbusinesswire.comMore in BiotechAusperBio · Series CProFound Therapeutics · StrategicTransfyr · SeedBiotechUnited StatesNorth AmericaSeries B